The published version of Forbes Future of Work newsletter delivers the latest news for chief human resources officers and other talent managers on disruptive technologies, managing the workforce and trends in the remote work debate to your inbox every Friday.
Drugs like Ozempic and Wegovy can cost upwards of $1,000 a month without insurance, but the drugs’ ability to help employees’ health in the long term could lead more employers to cover them under medical plans.
U S employers covering weight-loss drugs could nearly double in 2024 - survey reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Nearly double the number of employers plan to cover weight loss drugs in 2024, according to survey findings from Accolade. 81% of HR leaders believe their emplo
The number of US employers who cover obesity medications, including Wegovy from Novo Nordisk that belongs to a class of GLP-1 drugs, could nearly double next year, according to a survey.